Bozhou’s medicinal herb exports exceed US$44 million in first four months of 2026
Bozhou, a historic hub for traditional Chinese medicine (TCM) in Anhui Province, exported US$44.7 million worth of medicinal herbs during the first four months of 2026, a 37 per cent increase over the same period in 2025. This growth, reported by the Belt and Road News Network, highlights the city’s shift from raw material supply to high-value pharmaceutical production. With total trade volume reaching US$114 million in 2025, Bozhou now commands nearly 90 per cent of Anhui’s medicinal plant trade.
Why is Bozhou shifting toward high-value pharmaceutical manufacturing?
Local producers are moving away from raw exports to capture higher profit margins through processing and patent-protected goods. According to the Bozhou Pharmaceutical Industry Development Bureau, this pivot relies on standardized quality control and direct agronomic support for farmers. By providing technical guidance and purchasing raw materials above market rates, manufacturers ensure the medicinal characteristics of plants remain consistent for international clinical standards.
How does regional trade policy influence TCM exports?
The establishment of the permanent secretariat for the Traditional Chinese Medicine Cooperation Council in September 2024 has formalized trade routes under the Regional Comprehensive Economic Partnership (RCEP). Data from the Bozhou Pharmaceutical Industry Development Bureau indicates that 210 local enterprises now utilize this framework to maintain trade relations with RCEP member countries. This institutional support helps bridge the gap between Chinese producers and ASEAN markets, simplifying the entry process for traditional herbs like Paeonia lactiflora and liquorice.

What is the impact of localized packaging on international sales?
Success in Southeast Asian markets, including Thailand, Vietnam, and Malaysia, is frequently tied to regional market adaptation. One local producer cited by the Belt and Road News Network reported annual export volumes hitting US$4 million after customizing product labels and packaging formats to meet local consumer preferences. This move contrasts with traditional bulk-export models, which often lack the localized branding necessary to compete with domestic pharmaceutical alternatives in international markets.

Frequently Asked Questions
- What is the primary export market for Bozhou’s medicinal herbs? Southeast Asian nations, including Vietnam, Thailand, and Malaysia, are major growth markets supported by RCEP trade agreements.
- How much of Anhui Province’s medicinal trade comes from Bozhou? Bozhou accounts for nearly 90 per cent of the total medicinal plant trade in Anhui Province, according to 2025 data.
- Why are Bozhou companies moving toward patents? Patents allow manufacturers to secure higher value-added status for their goods, moving beyond the thin margins associated with raw herb exports.
Are you interested in the intersection of traditional medicine and global trade? Subscribe to our newsletter for monthly updates on industry trends, or explore our archives for more analysis on the evolving pharmaceutical landscape.